Business Description
Avivagen Inc
NAICS : 325412
SIC : 3741
ISIN : CA05382F2026
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -33.94 | |||||
Debt-to-Equity | -0.78 | |||||
Debt-to-EBITDA | -2.67 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -310.32 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -20.6 | |||||
3-Year EBITDA Growth Rate | 17.5 | |||||
3-Year EPS without NRI Growth Rate | 34.7 | |||||
3-Year FCF Growth Rate | 23.7 | |||||
3-Year Book Growth Rate | 5.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
14-Day RSI | 43.09 | |||||
6-1 Month Momentum % | -50 | |||||
12-1 Month Momentum % | -83.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.03 | |||||
Quick Ratio | 0.02 | |||||
Days Inventory | 302.33 | |||||
Days Sales Outstanding | 74.43 | |||||
Days Payable | 812.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -30.3 | |||||
Shareholder Yield % | 600.57 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 42.74 | |||||
Operating Margin % | -228.63 | |||||
Net Margin % | -648.05 | |||||
FCF Margin % | -102.37 | |||||
ROA % | -553.57 | |||||
ROIC % | -52.49 | |||||
ROC (Joel Greenblatt) % | -3517.72 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.33 | |||||
EV-to-EBIT | -2.74 | |||||
EV-to-EBITDA | -2.8 | |||||
EV-to-Revenue | 10.63 | |||||
EV-to-FCF | -10.38 | |||||
Price-to-Median-PS-Value | 0.01 | |||||
Earnings Yield (Greenblatt) % | -36.5 | |||||
FCF Yield % | -188.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Avivagen Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 0.716 | ||
EPS (TTM) (C$) | -0.06 | ||
Beta | 1.18 | ||
Volatility % | 107.14 | ||
14-Day RSI | 43.09 | ||
14-Day ATR (C$) | 0.00001 | ||
20-Day SMA (C$) | 0.005 | ||
12-1 Month Momentum % | -83.33 | ||
52-Week Range (C$) | 0.005 - 0.03 | ||
Shares Outstanding (Mil) | 77.69 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Avivagen Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Avivagen Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Avivagen Inc Frequently Asked Questions
What is Avivagen Inc(TSXV:VIV)'s stock price today?
When is next earnings date of Avivagen Inc(TSXV:VIV)?
Does Avivagen Inc(TSXV:VIV) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |